SCHEMBL14615758

SCHEMBL14615758

CCOC(=O)CC(C=O)Nc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ TSHR P16473 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ MAPT P10636 3/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ PPID Q08752 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ CTSK P43235 1/20 0.40
▸ DHODH Q02127 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11017995 0.82 ALDH1A1 (0.48) ALDH1A1TSHRGAAMAPTTDP1
SCHEMBL3939343 0.81 ALDH1A1 (0.50) ALDH1A1TSHRGAAMAPTTDP1
SCHEMBL11020359 0.80 GAA (0.53) ALDH1A1TSHRGAAMAPTTDP1
SCHEMBL7379537 0.79 ALDH1A1 (0.48) ALDH1A1TSHRGAAMAPTTDP1
SCHEMBL4408344 0.79 ALDH1A1 (0.48) ALDH1A1TSHRGAAMAPTTDP1
SCHEMBL28242825 0.78 ALDH1A1 (0.47) ALDH1A1TSHRGAAMAPTTDP1
SCHEMBL8121589 0.78 ALDH1A1 (0.47) ALDH1A1TSHRGAAMAPTTDP1
SCHEMBL13300766 0.77 CTSK (0.52) MEN1KMT2ALMNACTSK
SCHEMBL7986231 0.77 CTSK (0.52) MEN1KMT2ALMNACTSK
SCHEMBL30305384 0.77 ALDH1A1 (0.46) ALDH1A1TSHRGAAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7183281-B2 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists ELAN PHARMACEUTICALS, INC. (US) 2007-02-27 — — US disclosed
Send feedback